Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Clinical Laboratory Techniques | 2 | 2018 | 24 | 0.620 |
Why?
|
| Blood Cell Count | 1 | 2018 | 30 | 0.540 |
Why?
|
| Hematologic Tests | 1 | 2018 | 13 | 0.540 |
Why?
|
| Pathology, Clinical | 1 | 2018 | 16 | 0.540 |
Why?
|
| Bone Marrow | 3 | 2018 | 77 | 0.540 |
Why?
|
| Bone Marrow Examination | 3 | 2015 | 7 | 0.460 |
Why?
|
| Biopsy | 1 | 2008 | 273 | 0.260 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 542 | 0.260 |
Why?
|
| Anemia | 3 | 2018 | 58 | 0.240 |
Why?
|
| Precancerous Conditions | 1 | 2005 | 26 | 0.220 |
Why?
|
| Leukemia | 1 | 2005 | 44 | 0.220 |
Why?
|
| Lymphocytes | 1 | 2005 | 59 | 0.220 |
Why?
|
| Substance-Related Disorders | 1 | 2005 | 140 | 0.200 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2002 | 21 | 0.180 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2018 | 9 | 0.140 |
Why?
|
| Retrospective Studies | 4 | 2015 | 3825 | 0.140 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2018 | 1 | 0.140 |
Why?
|
| Middle Aged | 5 | 2018 | 12726 | 0.140 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 20 | 0.130 |
Why?
|
| Iron | 1 | 2018 | 121 | 0.130 |
Why?
|
| Endometriosis | 1 | 2018 | 103 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 135 | 0.120 |
Why?
|
| Child | 2 | 2018 | 2614 | 0.120 |
Why?
|
| Humans | 9 | 2018 | 34562 | 0.110 |
Why?
|
| Female | 5 | 2018 | 21532 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2008 | 4157 | 0.080 |
Why?
|
| Aged | 3 | 2018 | 11022 | 0.080 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2010 | 2 | 0.080 |
Why?
|
| Burkitt Lymphoma | 1 | 2010 | 7 | 0.080 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 8 | 0.080 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 9 | 0.080 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2011 | 82 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2011 | 256 | 0.080 |
Why?
|
| Students, Medical | 1 | 2011 | 136 | 0.070 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2008 | 7 | 0.070 |
Why?
|
| Hematologic Diseases | 1 | 2008 | 25 | 0.070 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2008 | 27 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2011 | 926 | 0.070 |
Why?
|
| Lymphoma | 1 | 2008 | 40 | 0.070 |
Why?
|
| Male | 4 | 2015 | 20740 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2011 | 349 | 0.070 |
Why?
|
| Immunophenotyping | 2 | 2010 | 51 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2010 | 198 | 0.060 |
Why?
|
| Cell Count | 1 | 2005 | 55 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2005 | 100 | 0.050 |
Why?
|
| Acute Disease | 1 | 2005 | 277 | 0.050 |
Why?
|
| Bone Marrow Cells | 2 | 2018 | 125 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 197 | 0.050 |
Why?
|
| Prothrombin | 1 | 2002 | 2 | 0.050 |
Why?
|
| Factor V | 1 | 2002 | 7 | 0.050 |
Why?
|
| Point Mutation | 1 | 2002 | 32 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2002 | 3 | 0.050 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2002 | 4 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2002 | 49 | 0.050 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2002 | 9 | 0.050 |
Why?
|
| Cytogenetic Analysis | 1 | 2002 | 18 | 0.050 |
Why?
|
| HLA-DR Antigens | 1 | 2002 | 8 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2002 | 13 | 0.050 |
Why?
|
| Karyotyping | 1 | 2002 | 29 | 0.050 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2002 | 21 | 0.050 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 21 | 0.050 |
Why?
|
| Antigens, CD34 | 1 | 2002 | 61 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2002 | 106 | 0.040 |
Why?
|
| Infant | 1 | 2005 | 1123 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2005 | 1355 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2002 | 215 | 0.040 |
Why?
|
| Adolescent | 2 | 2005 | 3805 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 849 | 0.040 |
Why?
|
| Peptide Hormones | 1 | 2018 | 11 | 0.040 |
Why?
|
| Menstrual Cycle | 1 | 2018 | 68 | 0.030 |
Why?
|
| Neoplasms | 1 | 2005 | 793 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2018 | 355 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2018 | 549 | 0.030 |
Why?
|
| Adult | 2 | 2005 | 10030 | 0.030 |
Why?
|
| Models, Educational | 1 | 2011 | 22 | 0.020 |
Why?
|
| Feedback | 1 | 2011 | 42 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 111 | 0.020 |
Why?
|
| Data Collection | 1 | 2011 | 191 | 0.020 |
Why?
|
| Software | 1 | 2011 | 130 | 0.020 |
Why?
|
| Educational Status | 1 | 2011 | 185 | 0.020 |
Why?
|
| Learning | 1 | 2011 | 88 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2011 | 122 | 0.020 |
Why?
|
| Perception | 1 | 2011 | 107 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 71 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 36 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 175 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 585 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 278 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 341 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 600 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 939 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 8579 | 0.010 |
Why?
|
| Iowa | 1 | 2002 | 9 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 92 | 0.010 |
Why?
|
| Heterozygote | 1 | 2002 | 66 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 204 | 0.010 |
Why?
|
| United States | 1 | 2011 | 4278 | 0.010 |
Why?
|
| Cause of Death | 1 | 2002 | 245 | 0.010 |
Why?
|
| DNA | 1 | 2002 | 235 | 0.010 |
Why?
|